Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Clinical trial NCT06616584 · RECRUITING

Trial details

NCT number: NCT06616584
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Recurrent Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

Start date: 2025-05-22
Primary completion: 2027-12-31
Enrollment: 378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.